AL-1095

AL-1095
Clinical data
ATC code	none;
Legal status
Legal status	In general: unscheduled;
Identifiers
	IUPAC name 2-(1-phenyl-1-(p-chlorophenyl)methyl)-3-hydroxyquinuclidine;
CAS Number	54549-19-8 ;
PubChem CID	3041659;
ChemSpider	2304906 ;
UNII	FBM6V6H8CK;
CompTox Dashboard (EPA)	DTXSID60969780 ;
Chemical and physical data
Formula	C20H22ClNO
Molar mass	327.85 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES OC(C1CCN2CC1)C2C(C3=CC=C(Cl)C=C3)C4=CC=CC=C4;
	InChI InChI=1S/C20H22ClNO/c21-17-8-6-15(7-9-17)18(14-4-2-1-3-5-14)19-20(23)16-10-12-22(19)13-11-16/h1-9,16,18-20,23H,10-13H2/t18?,19-,20+/m0/s1 ; Key:JXCMZYHEZWCLOD-NRRUETGQSA-N ;
	(what is this?) (verify)

AL-1095, is a centrally acting stimulant drug with comparable effects to amphetamine, developed by Bristol in the 1970s.

Clinical data

ATC code	none
Legal status
Legal status	In general: unscheduled
Identifiers
IUPAC name 2-(1-phenyl-1-(p-chlorophenyl)methyl)-3-hydroxyquinuclidine
CAS Number	54549-19-8^Y
PubChem CID	3041659
ChemSpider	2304906^Y
UNII	FBM6V6H8CK
CompTox Dashboard (EPA)	DTXSID60969780
Chemical and physical data
Formula	C₂₀H₂₂ClNO
Molar mass	327.85 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES OC(C1CCN2CC1)C2C(C3=CC=C(Cl)C=C3)C4=CC=CC=C4
InChI InChI=1S/C20H22ClNO/c21-17-8-6-15(7-9-17)18(14-4-2-1-3-5-14)19-20(23)16-10-12-22(19)13-11-16/h1-9,16,18-20,23H,10-13H2/t18?,19-,20+/m0/s1^Y Key:JXCMZYHEZWCLOD-NRRUETGQSA-N^Y
^NY (what is this?) (verify)